Hyaluronic Acid Experts - Disamed
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
S P E CIAL I S T S I N T H E DE VE LOP M E NT, P R O D U C T I ON A N D DIST R IB U T ION OF Hya l ur o n i c a c i d - b a se d pr o du c t s 2007 2008 2011 2013 2015 2016 2017 2018 2019 2020 Creation of Launch of Launch of Opening of new Launch of Opening Launch of an innovative Launch of a new Opening of Extension of Laboratoires VIVACY Aesthetics range, Gynecology range, production site in dermocosmetics range, of Geneva RFID-based product generation injection London and production site and in Paris, France STYLAGE® DESIRIAL® Archamps, France STYLAGE ® SKIN PRO subsidiary authenticity method, delivery system, Moscow opening of subsidiary VIVACY Security ® Bi-SOFT® subsidiaries in Warsaw PRODUCTS IN TERN ATIO N AL PRESEN CE Distrib ution networks in • STYLAGE® : medical devices used for aesthetic medicine. • DESIRIAL® : medical devices used for functional and aesthetic gynecology. • STYLAGE® SKIN PRO : premium range of hyaluronic acid-based dermocosmetics. over 75 countries
ON LY A U TH E N T I C PRODUCTS VIVACY SECURITY ® tags with integrated RFID OU R (Radio Frequency Identification) chips are placed inside each box to easily verify the origin of STYLAGE ® and E X C L U SIVE DESIRIAL ® injectables with a Smartphone through a dedicated mobile app, “My Vivacy”. TE CH N OLOGIES Download for free on AppStore and GooglePlay. Quality and safety have always been N E X T-G E N E R ATI ON SYRINGES a part of the VIVACY DNA. As a manufacturer, Laboratoires VIVACY controls all In its continuing quest for innovative excellence, stages of production and no compromise is made. VIVACY developed Bi-SOFT ® Injection Technology to provide greater precision, comfort and control for Our global mission is to introduce innovations that Physicians during their day-to-day injections with provide new services and types of experiences to the STYLAGE ® dermal fillers. Medical Aesthetics Industry. Why is this? Because new technologies can dramatically influence the way a product is chosen to safely perform PATE N TE D H YA L U RONIC ACID aesthetic treatments. STYLAGE ® products are based on the unique patented IPN-Like Technology¹ to accurately define each product’s viscoelastic properties. Antioxidants are then added to the HA gels to preserve the formulation from scavenging free radicals during the injection² ³. 1 IPN-Like Technology Patent delivered WO2009/071697 in 2008. 2 Smirnoff, N., Cumbes, Q. J. “Hydroxyl radical scavenging activity of compatible solutes”. Journal of Phytochemistry (1989) Vol. 28, no. 4: 1057-1060. 3 Mendoza G & Al. “Inhibitory effects of different antioxidants on hyaluronan depolymerisation” Carbohydrate Research 342 (2007); 96-102.
B i-S O F T ® INJ E C T I O N T EC H N O LOGY B i- M AT E R IA L T E CH N OL OG Y • Made of po lycar bona t e . • A « so ft -t o uch » s u rfa c e . • Highly t r ansparent m a t e r i a l . • Designed in 5 diffe re nt OP T I M I S E D C E N T E R OF G R AV I T Y co lo r-co des to qu i c kl y • Erg o n o mi c de si g n fo r i n c re a se d p hy s i c i a n ’s identify the produc t s. c om for t . • A l a rg e r o v a l g ri p pl a t e fo r b e t t e r ha nd l in g o f t h e sy ri n g e a n d a n e a si e r pro du c t a dmi n i st ra t i o n . In its continuing quest for innovative excellence in Medical Aesthetic market, Laboratoires VIVACY has developed a unique delivery system, Bi-SOFT ® Injection Technology. greater The syringe offers precision , comfort and control . It is specifically designed to support physicians in the daily practice of aesthetic treatments. I N J E C TI ON V OL U M E C ONTROL • Top d ow n bl u e g ra du a t i on . • G ood re a d a b i l i t y. HA ND L ING A B IL IT Y • R educt io n o f t he inj e c t i on fo rce sensat io n. • Provides extra grip and stability between the surface of the syringe and the gloves.
IPN-LIKE TECHNOLOGY PRODUCT RHEOLOGY Our patented IPN-Like Technology consists of 2 interpenetrated networks of IPN-Like Technology² accurately defines each products monophasic cross-linked hyaluronic acid. The cross-linking action stabilizes the hyaluronic viscoelastic properties. The elastic and viscous components allow the gel to obtain the acid in order to increase the longevity of the product in the tissues¹. desired properties³: ability to lift, mechanical support and ease of spreading. Monophasic cross-linked network A Monophasic cross-linked network B + = Monophasic cross-linked network A Monophasic cross-linked network B Interpenetrated networks: Monophasic Monophasic cross-linked network A Monophasic Monophasic cross-linked network B Interpenetrated networks: Monophasic IPN-Like Network cross-linked network A cross-linked network B Monophasic IPN-Like Network THE IN T E R PE N E T R AT ION Interpenetrated networks: O F CROMonophasic SInterpenetrated S Monophasic - L IIPN-Like NK ENetwork D Network networks: IPN-Like NE T WORK S E NAB LE S²: THE I NJECTI ON PLAN is determined by the aesthetic indication that needs to be treated. The optimization of product rheology and, in particular, the viscosity to guarantee good “injectability”. Once it has been determined, the physician may choose the STYLAGE® The conservation of the partial independence of the interpenetrated networks, whilst increasing the hyaluronic acid dermal filler with the most adapted rheological density of chemical nodes, to limit the degradation of the gel and optimize its duration. properties for the procedure. The cohesion of the hyaluronic acid gel and its monophasic properties. All STYLAGE® products contain an antioxidant, Mannitol or Sorbitol*, which protects the hyaluronic acid gel against Free Radicals (oxidative stress) which 1 2 Tezel, A et al. “The science of hyaluronic acid dermal fillers”. Journal of Cosmetic and Laser Therapy (2008); 10: 35-42. IPN-Like Technology Patent WO2009/071697 in 2008. are generated during injections³. It also minimizes the degradation of the gel4. 3 Sundaram, H. et al.. “Biophysical characteristics of hyaluronic acid soft-tissue fillers and their relevance to aesthetic applications”. American Society of Plastic Surgeons (2013). DOI: 10.1097. 4 Mendoza G & Al. “Inhibitory effects of different antioxidants on hyaluronan depolymerisation” Carbohydrate Research 342 (2007); 96-102. * STYLAGE ® Hydromax only
CO M P L E T E D E R M A L F I L L ER R A NGE Wrinkle filling & smoothing S TYL E Y O UR AGE! Lip enhancement A full range of monophasic injectable dermal fillers cross-linked using VIVACY’s Facial volume restoration patented IPN-Like Technology* W ith o r witho ut LIDOCA INE** Skin hydration & elasticity improvement * Except STYLAGE ® Hydro which is non-cross-linked ** STYLAGE ® XXL, STYLAGE ® Hydro and STYLAGE ® Hydromax are not available with Lidocaine
S TYL A G E ® D ER M A L FILLE RS P R O DU C T R A N G E OVE RVIE W M L XL XXL HYDRO HYDROMAX Cross-linked HA IPN-Like Cross-linked HA IPN-Like Cross-linked Non-cross-linked Cross-linked HA Composition + Mannitol Option available with + Mannitol Option available with HA IPN-Like HA IPN-Like Lidocaine (0.3%) Lidocaine (0.3%) + Mannitol + Mannitol + Sorbitol Concentration 16 mg/g 20 mg/g 24 mg/g 18.5 mg/g 26 mg/g 21 mg/g 14 mg/g 12.5 mg/g 2 x 1 ml + 2 x 1 ml + 27G½’’ 1 x 1ml + 2 x 0.8 ml + 2 x 1 ml + 2 x 1 ml + 1 x 1ml + 1 x 1ml + Pack Contents 30G½’’ Needle 30G½’’ Needle 27G½’’ Needle 30G½’’ Needle 27G½’’ & 23G¼’’ Needle & 25G40mm 30G ’’ Needle 30G ’’ & 30G½’’ Needles Cannula Needles Facial volume Fine to Medium Medium to deep Deep to very deep Facial Volume Indications Wrinkles, Lips wrinkles, Lips wrinkles Lips Restoration restoration & Moisturisation creation Superficial Superficial to Mid to Deep to Into or around Deep dermis or dermis/ Mid to mid dermis deep dermis very deep dermis labial mucosa subcutaneous dermo-epidermal deep dermis junction Depth of Injection Duration 6 to 12 Months 6 to 12 Months 12 to 18 Months --
FOR HER FOR HIM S Glabella Temples M XL XXL M XL XXL Temples S Crow’s Feet Cheekbones XL XXL M L Nose Nose M L XL XXL Cheekbones Cheeks M M Cheeks Nasolabial Folds M L M L Nasolabial Folds S Perioral area Lips S M SPECIAL LIPS S HYDROMAX Labial Commissures S M SPECIAL LIPS Lips XL XXL Facial Oval Jawline XL XXL M L Marionette lines XL XXL Chin Chin XL XXL HYDRO HYDROMAX Neck L HYDROMAX Back of Hand HYDRO HYDROMAX Décolleté
WRINKLE FILLING & SMOOTHING PRODUCT INDICATIONS: Fill wrinkles and visibly smooth the surface of the skin. for fine (superficial for moderate to for deep to very to moderate) lines. deep lines. deep lines. INJECTION PLAN: Injection of the gel at a superficial to deep dermis level depending on product chosen and the area being treated.
LIP CORRECTION PRODUCT INDICATIONS: Specially designed to treat all indications related to the ageing of the lips. Lip volume augmentation. Rehydration of the lips. Definition of lip contour. INJECTION PLAN: Injection into and around the labial mucosa using conventional techniques (retrograde tracing, micro-bolus).
RESTORING VOLUME PRODUCT INDICATIONS: Restore the contours of the face by replenishing volumes that are lost over time. for facial volume restoration or augmentation. INJECTION PLAN: Injection into the deep dermis and/or subcutaneously depending on the technique used and the desired effect.
MOISTURISING ACTION PRODUCT INDICATIONS: Mesotherapy range dedicated to improving skin moisturisation and elasticity. Non-cross-linked hyaluronic Cross-linked hyaluronic acid (14mg/g). acid (12.5mg/g). INJECTION PLAN: Injection with multiple micro-injections into the superficial or deep dermis* of the face, neck, décolleté or back of the hand. * Depending on the condition of the skin, the product and the chosen technique
A D D ITION OF L I D O C AINE PATIE N T C O M F OR T WANT TO MASTER YOUR INJECTION SKILLS? Laboratoires VIVACY developed a formula containing the anesthetic, Lidocaine, to make injections less painful and improve the patient’s comfort during the procedure. STYLAGE ® “with lidocaine” reduces discomfort at the moment of the injection and guarantees that the product performance is the same as that of the products without Lidocaine¹. WA NT T O MA STER Y O UR 100 INJ E C T IO N SKI LLS? DISTRIBUTION OF PATIENTS (%) BY LEVEL OF PAIN EXPERIENCED (1) STYLAGE ® M 80 STYLAGE ® M Lidocaine 60 JOIN FOR FREE & LEARN FROM OUR EXPERTS 60 VIVACY-LEARN.COM 50 40 40 30 20 20 10 0 0 Light Moderate Strong Light Moderate Strong During injection During massage JOIN FOR FREE & LEARN FROM OUR EXPERTS V I VA C Y- L E A R N . C OM HIGH LEVEL KEY OPINION 4 NEW VIDEOS REGULAR LIVE FACIAL & INTIMATE 1 Môle B, Gozlan L. – “Benefits of adding lidocaïne to a hyaluronic gel – STYLAGE ® M” – J. Cosm and laser therapy – 2011 Oct – 13(5): 249-254. Post-CE Marking single-blind clinical TRAININGS LEADERS EACH MONTH WEBINARS AESTHETICS study performed on 84 patients comparing Stylage ® M versus Stylage ® M lidocaine. Level of pain experienced by patient during injection and massage measured on a scale from 1 to 10.
B E FO R E BEFO RE A FTE R AFTER ST YL A G E ® HYDROMAX: C H E EKS STYLAGE ® M: CHEEKS, NASOGENI AN FOLDS © Copyright – Dr Maria Grazia Caputo (IT) © Copyright – Dr Sylvie Poignonec (FR) STYLAGE ® L : NOSE ST YL A G E ® S P E C I A L L I P S : L I PS STYLAGE ® X X L : JAWLI NE, CHEEKB ONES, CHI N © Copyright – Dr James Schinazi (FR) © Copyright – Dr Jasmin Taher (UK) STYLA G E ® S : F O R E H E A D , G LABEL L A, EY E W RINKL ES STYLAGE ® X L : CHI N © Copyright – Dr Natalia Romanowska (PL) © Copyright – Pr Ali Mojallal (FR)
M A D E I N F R A N C E v i v a c y l a b . c o m LABORATOIRES VIVACY 44, rue Paul Valéry - 75116 Paris, France Tel : +33 (0)1 56 90 08 08 Manufacturer LABORATOIRES VIVACY 252, rue Douglas Engelbart - Archamps Technopôle - 74160 ARCHAMPS, France Tel : +33 (0)4 50 31 71 81 Medical Devices Class III, regulated health products bearing the CE marking (CE 0344) in accordance with Medical Device Regulation. MK461 vB (06.2020) - lemahieudesign
You can also read